Major surgery in haemophilic patients with inhibitors using recombinant factor vila

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue , 1996, Pages 118-123

  Ingerslev, J ^a   Freidman, D ^b   Gastineau, D ^c   Gilchrist, G ^c   Johnsson, H ^d   Lucas, G ^e   Mc Pherson, J ^f   Preston, E ^g   Scheibel, E ^h   Shuman, M ⁱ  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c MAYO CLINIC   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^f UNIVERSITY OF NEWCASTLE   (Australia)

^g ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^h Mental Health Services CPH   (Denmark)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Factor VIII inhibitors; Factor VIla; Haemophilia; Recombinant factor VIla; Surgery

Indexed keywords

BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ADULT; BLEEDING; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HEMOPHILIA; HUMAN; MALE; PRIORITY JOURNAL; SURGERY;

ADOLESCENT; ADULT; ANTIBODY FORMATION; CHILD; FACTOR VIIA; HEMOPHILIA A; HUMANS; MONITORING, PHYSIOLOGIC; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS;

EID: 9044244906     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217252     Document Type: Article

References (15)

1. Fhrenfort S, Krcuz W, Scharrer I, Linde R, Funk M, Gtingor T, Krack-hardt B, Komhubcr B: Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 1992;339:594-598.
2. Brcttlcr DB: Inhibitors of factor VIII and IX. Haemophilia 1995,1 (suppl 1):35-39.
3. Gatti L. Mannucci PM: Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies. Thromb Haemost 1984;51:379-384.
4. Brettler DB, Forsberg AD, Levine PH, Aledort LM. Hilgartncr MW, Kasper CK, Lusher JM. McMillan C, Roberts HR, Cooperating investigators: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. Arch Intern Med 1989;149:1381-1385.
5. Lozier JN. Santagostini E, Kasper CK, Teitel JM, Hay CR: Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors Semin Hcmatol 1993;30/ 2 (suppl 1): 10-21.
6. Warrier I, Kucfller S. Pfaffmann L, Lusher J: Use of porcine F VIII Hyatc:C) for hemostasis during surgery in children with factor VIII inhibitor (abstract 71). 21st International Congress of the World Federation of Hemophilia, Mexico City. 1994.
7. Lusher JM: Thrombogenicity associated with factor IX complex concentrates. Semin Hematol 1991;28/ 3(suppl 6):3-5.
8. Penner JA: Treatment of inhibitor patients with activated prothrombin complex concentrates; in Hoyer LW (ed): Factor VIII Inhibitors. Prog Clin Biochem Res New York. Liss, 1984, vol 170, pp 291-307.
9. Hutchinson RJ, Penner JA. Hensin-ger RN: Anti-inhibitor coagulant complex (Autoplex) in hemophilia inhibitor patients undergoing synovectomy. Pediatrics 1983;71: 631-633.
10. Negrier C, French Feiba Study Group: Multicenter retrospective study on the utilization of Feiba in France in patients with factor VIII and factor IX inhibitors (Abstract 23). 2nd International Symposium on Inhibitors to Coagulation Factors, University of North Carolina at Chapel Hill, 1993.
11. Lauroroa P. Barbier F, Dieu P, Du-mora D. Mouliner J: Prothesc bilat-erale genou chcz un hemophilie A avec inhibitcur. Ann Fr Anesth Reanim 1986;5:154-156.
12. Christiansen SE. Ingerslev J. Walle-vik K, Farso F, Helmig O, Stenbjerg S: Management of anterior compartment syndrome in two high responder factor VIII inhibitor patients with activated prothrombin complex concentrate. Thromb Res 1986:42:707-712.
13. Sindet-Peterscn S, Stenbjerg S, In-gcrslev J: Treatment of bilateral fracture of the mandible in a hemophilic patients with inhibitor to factor VIII. J Oral Maxillofac Surg 1987;45:537-540.
14. Glazer S, Hedncr U. Falch J: Pathologic inhibitors: Management with factor Vila; in Green D (ed): Anticoagulants. Physiologic, Pathologic and Pharmacologic. Boca Raton, CRC Press, 1994. pp 131-141.
15. Gringeri A, Santagostini E, Mannucci PM: Failure of recombinant activated factor VII during surgery in a haemophiliac with high-titer factor VIII antibody. Haemostasis 1991;21:1-4.